News/ News/ Oncology/ Top stories Lilly claims another victory in Alimta patent defence Phil Taylor Alimta, Apotex, Eli Lilly, generic, Oncology 0 Comment Eli Lilly ended 2019 with a win in its long-running legal battle to prevent generics of its big-selling Share X Lilly claims another victory in Alimta patent defence https://pharmaphorum.com/news/lilly-claims-another-victory-in-alimta-patent-defence/
Market Access/ News/ News Mylan up on OK for generic of Lilly’s $2bn cancer drug Alimta Phil Taylor Alimta, Eli Lilly, generic, lung cancer, Mylan 0 Comment Shares in Mylan have risen after the FDA gave a tentative approval to its generic version of Eli Share X Mylan up on OK for generic of Lilly’s $2bn cancer drug Alimta https://pharmaphorum.com/news/mylan-up-on-ok-for-generic-of-lillys-2bn-cancer-drug-alimta/
